PTCE - Medications (35% of the exam) - Section 1.6

State the therapeutic indications of medications.

State the FDA-approved therapeutic use for commonly dispensed medications and distinguish primary approved indications from off-label uses. Recognise that a drug's therapeutic class shapes which patient conditions it targets and how it is categorised in a formulary.

Drug indicationTherapeutic useFDA-approved indication

Practice question for this objective

Free sampleMedicationsmedium

A prescriber's office calls and asks the technician to confirm whether the omeprazole the pharmacy stocks is in the same therapeutic class as the patient's previous pantoprazole, because the patient reported the old medicine controlled her reflux well. To answer correctly, which classification do both medicines share?

  • AHistamine H2-receptor antagonists, which block acid at the H2 receptor
  • BAntacids, which neutralise acid already present in the stomach
  • CProkinetic agents, which speed gastric emptying to reduce reflux
  • DProton pump inhibitors, which block the gastric acid-secreting enzyme Correct
Recognise that drugs sharing a suffix and mechanism belong to the same therapeutic class. The shared -prazole suffix signals the proton pump inhibitor class; both omeprazole and pantoprazole irreversibly inhibit the gastric hydrogen-potassium ATPase pump on parietal cells, suppressing acid production rather than neutralising it.

Why A is wrong: H2 antagonists such as famotidine also reduce stomach acid, which makes the class tempting, but omeprazole and pantoprazole act differently and do not belong to this group.

Why B is wrong: Antacids also treat reflux symptoms, making the choice plausible, but they neutralise existing acid rather than blocking its production as these two drugs do.

Why C is wrong: Prokinetics like metoclopramide can ease reflux by improving motility, which is tempting, but neither omeprazole nor pantoprazole works by that mechanism.

Why D is correct: Both omeprazole and pantoprazole are proton pump inhibitors that block the hydrogen-potassium ATPase enzyme, so they share the same therapeutic class and acid-suppressing action.

See more PTCE practice questions, answers explained.

Exam traps in Medications

Answers that look right on this material and are not. Each one is a distractor from a different question in the PTCE bank for this domain.

  • The chemical structure shared by the molecules, regardless of the condition the medicines are used to treat.

    Why it is wrong: Tempting because some classes do share structures, but grouping purely by chemical structure describes a chemical or structural class, not a therapeutic one.

  • Histamine H2-receptor antagonists that reduce acid

    Why it is wrong: H2 antagonists also reduce stomach acid, but that class includes ranitidine and famotidine, not these two agents.

  • They share the same pharmacologic class because both lower blood pressure, but they belong to different therapeutic classes because their brand names differ.

    Why it is wrong: Tempting because it uses the right vocabulary, but it swaps the definitions: shared mechanism defines pharmacologic class, not shared effect, and brand names do not define therapeutic class.

Examworthy is not affiliated with or endorsed by PTCB. Original, blueprint-aligned practice material only.